Aigen Investment Management, LP Apellis Pharmaceuticals, Inc. Transaction History
Aigen Investment Management, LP
- $579 Million
- Q1 2025
A detailed history of Aigen Investment Management, LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 15,621 shares of APLS stock, worth $319,761. This represents 0.06% of its overall portfolio holdings.
Number of Shares
15,621Holding current value
$319,761% of portfolio
0.06%Shares
10 transactions
Others Institutions Holding APLS
# of Institutions
305Shares Held
134MCall Options Held
2.97MPut Options Held
623K-
Avoro Capital Advisors LLC New York, NY12.2MShares$250 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$244 Million17.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$208 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$200 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.98MShares$184 Million0.03% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.25B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...